In a randomized, controlled trial of 168 seniors diagnosed with mild cognitive impairment, they found that TrioBe Plus slowed the rate
of brain shrinkage by an average
of 30 percent, and as much as 53 percent, according
to the study in PLoS One.
While all our brains shrink a little as we age, faster shrinkage has been linked to dementia and Alzheimer's disease. But if this B blend turns into a prescription "drug," you can expect rapid shrinkage somewhere else: your wallet!